Myelodysplastic syndromes (MDS) are blood cancers where bone marrow makes atypical red cells, white cells, or platelets. These cells may die early or not work well. Less aggressive MDS may still allow ...

Infection is the leading cause of death in LR-MDS patients, responsible for 24.6% of deaths within a year of diagnosis. Key risk factors for infection include intermediate or higher IPSS-R risk, ...